| UniProt ID | BEST1_HUMAN | |
|---|---|---|
| UniProt AC | O76090 | |
| Protein Name | Bestrophin-1 | |
| Gene Name | BEST1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 585 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . Basolateral cell membrane . |
|
| Protein Description | Forms calcium-sensitive chloride channels. Highly permeable to bicarbonate.. | |
| Protein Sequence | MTITYTSQVANARLGSFSRLLLCWRGSIYKLLYGEFLIFLLCYYIIRFIYRLALTEEQQLMFEKLTLYCDSYIQLIPISFVLGFYVTLVVTRWWNQYENLPWPDRLMSLVSGFVEGKDEQGRLLRRTLIRYANLGNVLILRSVSTAVYKRFPSAQHLVQAGFMTPAEHKQLEKLSLPHNMFWVPWVWFANLSMKAWLGGRIRDPILLQSLLNEMNTLRTQCGHLYAYDWISIPLVYTQVVTVAVYSFFLTCLVGRQFLNPAKAYPGHELDLVVPVFTFLQFFFYVGWLKVAEQLINPFGEDDDDFETNWIVDRNLQVSLLAVDEMHQDLPRMEPDMYWNKPEPQPPYTAASAQFRRASFMGSTFNISLNKEEMEFQPNQEDEEDAHAGIIGRFLGLQSHDHHPPRANSRTKLLWPKRESLLHEGLPKNHKAAKQNVRGQEDNKAWKLKAVDAFKSAPLYQRPGYYSAPQTPLSPTPMFFPLEPSAPSKLHSVTGIDTKDKSLKTVSSGAKKSFELLSESDGALMEHPEVSQVRRKTVEFNLTDMPEIPENHLKEPLEQSPTNIHTTLKDHMDPYWALENRDEAHS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTITYTSQV ------CCEEEEHHH | 23.25 | 29888752 | |
| 4 | Phosphorylation | ----MTITYTSQVAN ----CCEEEEHHHHH | 16.16 | 29888752 | |
| 5 | Phosphorylation | ---MTITYTSQVANA ---CCEEEEHHHHHH | 10.67 | 24043423 | |
| 6 | Phosphorylation | --MTITYTSQVANAR --CCEEEEHHHHHHC | 12.20 | 29888752 | |
| 7 | Phosphorylation | -MTITYTSQVANARL -CCEEEEHHHHHHCC | 16.55 | 29888752 | |
| 16 | Phosphorylation | VANARLGSFSRLLLC HHHHCCCHHHHHHHH | 25.33 | - | |
| 55 | Phosphorylation | FIYRLALTEEQQLMF HHHHHHCCHHHHHHH | 31.69 | 25690035 | |
| 111 | Phosphorylation | DRLMSLVSGFVEGKD HHHHHHHHHHCCCCC | 31.63 | 27732954 | |
| 131 | Phosphorylation | LRRTLIRYANLGNVL HHHHHHHHHCCCCEE | 7.89 | 18083107 | |
| 148 | Phosphorylation | RSVSTAVYKRFPSAQ EECCHHHHHHCCCHH | 8.25 | 18083107 | |
| 227 | Phosphorylation | QCGHLYAYDWISIPL HCCCCHHCCCCCCCC | 9.77 | - | |
| 358 | Phosphorylation | SAQFRRASFMGSTFN HHHHHHHHHCCCEEE | 17.60 | 19635817 | |
| 504 | Phosphorylation | TKDKSLKTVSSGAKK CCCCCCCCCCCCCHH | 30.80 | - | |
| 511 | Ubiquitination | TVSSGAKKSFELLSE CCCCCCHHHHHHHHH | 60.90 | - | |
| 536 | Phosphorylation | VSQVRRKTVEFNLTD HHHHHHHEEEECCCC | 24.37 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BEST1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BEST1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PP2AA_HUMAN | PPP2CA | physical | 12058047 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00527 | Retinitis pigmentosa (RP) | |||||
| H00805 | Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (S | |||||
| H00814 | Vitelliform macular dystrophy, including: Best disease / Juvenile vitelliform macular dystrophy (VMD | |||||
| OMIM Disease | ||||||
| 153700 | Macular dystrophy, vitelliform, 2 (VMD2) | |||||
| 613194 | Retinitis pigmentosa 50 (RP50) | |||||
| 611809 | Bestrophinopathy, autosomal recessive (ARB) | |||||
| 193220 | Vitreoretinochoroidopathy, autosomal dominant (ADVIRC) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...